138 related articles for article (PubMed ID: 8871001)
1. An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery.
Fernando IN; Powles TJ; Ashley S; Grafton D; Harmer CL; Ford HT
Clin Oncol (R Coll Radiol); 1996; 8(4):234-8. PubMed ID: 8871001
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital.
Fernando IN; Ford HT; Powles TJ; Ashley S; Glees JP; Torr M; Grafton D; Harmer CL
Clin Oncol (R Coll Radiol); 1996; 8(4):226-33. PubMed ID: 8871000
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
[TBL] [Abstract][Full Text] [Related]
4. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy.
Lingos TI; Recht A; Vicini F; Abner A; Silver B; Harris JR
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):355-60. PubMed ID: 2061112
[TBL] [Abstract][Full Text] [Related]
5. [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Miny-Buffet J; Favre A; Azria D; Body G; Le Floch O; Calais G
Cancer Radiother; 2006 Jun; 10(4):158-67. PubMed ID: 16632399
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
Koukourakis MI; Giatromanolaki A; Kouroussis C; Kakolyris S; Sivridis E; Frangiadaki C; Retalis G; Georgoulias V;
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):144-55. PubMed ID: 11777632
[TBL] [Abstract][Full Text] [Related]
9. Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer.
Lind PA; Marks LB; Hardenbergh PH; Clough R; Fan M; Hollis D; Hernando ML; Lucas D; Piepgrass A; Prosnitz LR
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):137-43. PubMed ID: 11777631
[TBL] [Abstract][Full Text] [Related]
10. [Radiation pneumonitis in the treatment of early-stage breast cancer].
Trofimova OP; Tkachev SI; Kostina NP; Maklakova AA; Timoshkina TV; Vekova NV; Glebovskaya VV; Zajchenko OS; Utkina VL; Alekseeva TR
Vopr Onkol; 2015; 61(1):116-20. PubMed ID: 26016156
[TBL] [Abstract][Full Text] [Related]
11. Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial.
Stein RC; Bower M; Law M; Bliss JM; Barton C; Gazet JC; Ford HT; Coombes RC
Eur J Cancer; 1992; 28A(12):1963-5. PubMed ID: 1419290
[TBL] [Abstract][Full Text] [Related]
12. Analysis of radiation pneumonitis and radiation-induced lung fibrosis in breast cancer patients after breast conservation treatment.
Nishioka A; Ogawa Y; Hamada N; Terashima M; Inomata T; Yoshida S
Oncol Rep; 1999; 6(3):513-7. PubMed ID: 10203583
[TBL] [Abstract][Full Text] [Related]
13. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
[TBL] [Abstract][Full Text] [Related]
14. Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
Astone A; Cassano A; Fontana T; Noviello MR; Pozzo C; Barone C
Anticancer Drugs; 1992 Oct; 3(5):471-3. PubMed ID: 1450440
[TBL] [Abstract][Full Text] [Related]
15. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
[TBL] [Abstract][Full Text] [Related]
16. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.
Kim TH; Cho KH; Pyo HR; Lee JS; Han JY; Zo JI; Lee JM; Hong EK; Choi IJ; Park SY; Shin KH; Kim DY; Kim JY
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):995-1002. PubMed ID: 15990000
[TBL] [Abstract][Full Text] [Related]
17. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
18. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure.
Rose MA; Henderson IC; Gelman R; Boyages J; Gore SM; Come S; Silver B; Recht A; Connolly JL; Schnitt SJ
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):711-7. PubMed ID: 2777660
[TBL] [Abstract][Full Text] [Related]
19. The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment.
Zygogianni A; Kouloulias V; Antypas C; Armpilia C; Kyrgias G; Kouvaris J
Breast J; 2014; 20(1):74-8. PubMed ID: 24237451
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk stage II-III and locally advanced breast carcinoma.
Stemmer SM; Pfeffer MR; Rizel S; Hardan I; Goffman J; Gezin A; Neumann A; Kitsios P; Alezra D; Brenner HJ
Cancer; 2001 Jun; 91(11):1983-91. PubMed ID: 11391576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
